These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26437339)

  • 1. Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis.
    Smith L; Baxter EW; Chambers PA; Green CA; Hanby AM; Hughes TA; Nash CE; Millican-Slater RA; Stead LF; Verghese ET; Speirs V
    PLoS One; 2015; 10(10):e0139698. PubMed ID: 26437339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dectection and analysis of miRNA expression in breast cancer-associated fibroblasts].
    Zeng Z; Hu P; Tang X; Zhang H; Du Y; Wen S; Liu M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1071-5. PubMed ID: 25270211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
    Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
    Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer.
    Hannafon BN; Sebastiani P; de las Morenas A; Lu J; Rosenberg CL
    Breast Cancer Res; 2011 Mar; 13(2):R24. PubMed ID: 21375733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.
    Zhao L; Sun Y; Hou Y; Peng Q; Wang L; Luo H; Tang X; Zeng Z; Liu M
    Int J Biochem Cell Biol; 2012 Nov; 44(11):2051-9. PubMed ID: 22964023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion.
    Verghese ET; Drury R; Green CA; Holliday DL; Lu X; Nash C; Speirs V; Thorne JL; Thygesen HH; Zougman A; Hull MA; Hanby AM; Hughes TA
    J Pathol; 2013 Nov; 231(3):388-99. PubMed ID: 23939832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-222 reprogrammed cancer-associated fibroblasts enhance growth and metastasis of breast cancer.
    Chatterjee A; Jana S; Chatterjee S; Wastall LM; Mandal G; Nargis N; Roy H; Hughes TA; Bhattacharyya A
    Br J Cancer; 2019 Oct; 121(8):679-689. PubMed ID: 31481734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
    Jones JL; Shaw JA; Pringle JH; Walker RA
    J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
    Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
    Schultz S; Bartsch H; Sotlar K; Petat-Dutter K; Bonin M; Kahlert S; Harbeck N; Vogel U; Seeger H; Fehm T; Neubauer HJ
    BMC Med Genomics; 2018 Sep; 11(1):80. PubMed ID: 30236106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling.
    Tang X; Hou Y; Yang G; Wang X; Tang S; Du YE; Yang L; Yu T; Zhang H; Zhou M; Wen S; Xu L; Liu M
    Cell Death Differ; 2016 Jan; 23(1):132-45. PubMed ID: 26068592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of deregulated microRNAs in breast cancer progression using FFPE tissue.
    Chen L; Li Y; Fu Y; Peng J; Mo MH; Stamatakos M; Teal CB; Brem RF; Stojadinovic A; Grinkemeyer M; McCaffrey TA; Man YG; Fu SW
    PLoS One; 2013; 8(1):e54213. PubMed ID: 23372687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.
    Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B
    Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a.
    Bertagnolo V; Grassilli S; Volinia S; Al-Qassab Y; Brugnoli F; Vezzali F; Lambertini E; Palomba M; Piubello Q; Orvieto E; Natali C; Piva R; Croce CM; Capitani S
    Mol Carcinog; 2019 May; 58(5):708-721. PubMed ID: 30582225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primed atypical ductal hyperplasia-associated fibroblasts promote cell growth and polarity changes of transformed epithelium-like breast cancer MCF-7 cells via miR-200b/c-IKKβ signaling.
    Sun Y; Yang D; Xi L; Chen Y; Fu L; Sun K; Yin J; Li X; Liu S; Qin Y; Liu M; Hou Y
    Cell Death Dis; 2018 Jan; 9(2):122. PubMed ID: 29374150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer.
    Citron F; Segatto I; Vinciguerra GLR; Musco L; Russo F; Mungo G; D'Andrea S; Mattevi MC; Perin T; Schiappacassi M; Massarut S; Marchini C; Amici A; Vecchione A; Baldassarre G; Belletti B
    Cancer Res; 2020 Mar; 80(5):1064-1077. PubMed ID: 31862778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of the tumor microenvironment during breast cancer progression.
    Ma XJ; Dahiya S; Richardson E; Erlander M; Sgroi DC
    Breast Cancer Res; 2009; 11(1):R7. PubMed ID: 19187537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
    Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL
    Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.